D, P., A, G., A, L., E, M., MC, N., VM, G., . . . P, L. (2022). Risk of Infection and Duration of Protection after the Booster Dose of the Anti-SARS-CoV-2 Vaccine BNT162b2 among Healthcare Workers in a Large Teaching Hospital in Italy: Results of an Observational Study. Vaccines, 11(1), . https://doi.org/10.3390/vaccines11010025
Chicago Style (17th ed.) CitationD, Pascucci, et al. "Risk of Infection and Duration of Protection After the Booster Dose of the Anti-SARS-CoV-2 Vaccine BNT162b2 Among Healthcare Workers in a Large Teaching Hospital in Italy: Results of an Observational Study." Vaccines 11, no. 1 (2022). https://doi.org/10.3390/vaccines11010025.
MLA (9th ed.) CitationD, Pascucci, et al. "Risk of Infection and Duration of Protection After the Booster Dose of the Anti-SARS-CoV-2 Vaccine BNT162b2 Among Healthcare Workers in a Large Teaching Hospital in Italy: Results of an Observational Study." Vaccines, vol. 11, no. 1, 2022, https://doi.org/10.3390/vaccines11010025.